Diagnosis and treatment of ADHD in adults in primary care

Journal of Clinical Psychiatry

Volumn 65, Issue SUPPL. 3, 2004, Pages 18-21

  Montano, Brendan ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b Building 1 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

ADULT; ATTENTION DEFICIT DISORDER; COMORBIDITY; HUMAN; MASS SCREENING; ONSET AGE; PRIMARY HEALTH CARE; PSYCHOLOGICAL RATING SCALE; REVIEW;

ADULT; AGE OF ONSET; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; HUMANS; MASS SCREENING; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES;

EID: 2142703728     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. Vital Health Statistics 10(200). 1999. Available at: http://www.cdc.gov/nchs/data/series/sr-10/ sr10-200.pdf. Accessed June 3, 2003
2. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD: an overview. Ann N Y Acad Sci 2001;931:1-16
3. Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94
4. Muntner P, Garrett E, Klag MJ, et al. Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 75 years of age. Stroke 2002; 33:1209-1213
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
6. Weiss M, Hechtman LT, Weiss G. ADHD in Adulthood: A Guide to Current Theory, Diagnosis, and Treatment. Baltimore, Md: Johns Hopkins University Press; 1999
7. Weiss G, Hechtman L, Milroy T, et al. Psychiatric status of hyperactiveness as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 1985;24:211-220
8. Brown TE, ed. Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. 3rd ed. Washington, DC: American Psychiatric Press; 2000
9. Pliszka SR, Carlson CL, Swanson JM. ADHD With Comorbid Disorders: Clinical Assessment and Management. New York, NY: Guilford Press; 1999
10. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for Axis I DSM-IV Disorders-Patient Edition (With Psychotic Screen) (SCID-I/P) (Version 2.0). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1996
11. Derogatis LR. Symptom Checklist-90 (Revised): Administration, Scoring, and Procedures Manual, II. Towson, Md: Clinical Psychometric Research; 1992
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
13. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
14. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
15. Adler LA, Kessler RC, Spencer T. Adult ADHD Self-Report Scale (ASRS) Screener. New York, NY: World Health Organization; 2003. Available at: http://www.med.nyu.edu/Psych/training/adhdscreener.pdf. Accessed Oct. 9, 2003
16. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885-890
17. Copeland ED. Copeland Symptom Checklist for Adult Attention Deficit Disorders. Atlanta, Ga: Southeastern Psychological Institute; 1989
18. Brown TE. Brown Attention-Deficit Disorder Scales. San Antonio, Tex: The Psychological Corporation; 1996
19. Conners CK, Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales (CAARS). North Tonawanda, NY: Multi-Health Systems; 1999
20. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003;53:112-120
21. Higgins ES. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit/hyperactivity disorder. J Fam Pract 1999;48:15-20
22. Popper CW. Antidepressants in the treatment of attention-deficit/ hyperactivity disorder. J Clin Psychiatry 1997;58(suppl 14):14-29
23. Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001;158:282-288